Michael Lefenfeld - Net Worth and Insider Trading

Michael Lefenfeld Net Worth

The estimated net worth of Michael Lefenfeld is at least $335,631 dollars as of 2024-11-13. Michael Lefenfeld is the Director of Immunome Inc and owns about 26,872 shares of Immunome Inc (IMNM) stock worth over $335,631. Details can be seen in Michael Lefenfeld's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael Lefenfeld has not made any transactions after 2021-05-26 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Michael Lefenfeld

To

Michael Lefenfeld Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Michael Lefenfeld owns 1 companies in total, including Immunome Inc (IMNM) .

Click here to see the complete history of Michael Lefenfeld’s form 4 insider trades.

Insider Ownership Summary of Michael Lefenfeld

Ticker Comapny Transaction Date Type of Owner
IMNM Immunome Inc 2021-05-26 director

Michael Lefenfeld Latest Holdings Summary

Michael Lefenfeld currently owns a total of 1 stock. Michael Lefenfeld owns 26,872 shares of Immunome Inc (IMNM) as of May 26, 2021, with a value of $335,631.

Latest Holdings of Michael Lefenfeld

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
IMNM Immunome Inc 2021-05-26 26,872 12.49 335,631

Holding Weightings of Michael Lefenfeld


Michael Lefenfeld Form 4 Trading Tracker

According to the SEC Form 4 filings, Michael Lefenfeld has made a total of 1 transactions in Immunome Inc (IMNM) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Immunome Inc is the acquisition of 4,650 shares on May 26, 2021, which cost Michael Lefenfeld around $86,165.

Insider Trading History of Michael Lefenfeld

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Michael Lefenfeld Trading Performance

GuruFocus tracks the stock performance after each of Michael Lefenfeld's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael Lefenfeld is -28.73%. GuruFocus also compares Michael Lefenfeld's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael Lefenfeld within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Michael Lefenfeld's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Michael Lefenfeld

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -9.27 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -11.29 LIMIT LIMIT LIMIT LIMIT LIMIT

Michael Lefenfeld Ownership Network

Ownership Network List of Michael Lefenfeld

No Data

Ownership Network Relation of Michael Lefenfeld

Insider Network Chart

Michael Lefenfeld Owned Company Details

What does Immunome Inc do?

Who are the key executives at Immunome Inc?

Michael Lefenfeld is the director of Immunome Inc. Other key executives at Immunome Inc include SVP Operations Max Rosett , Chief Scientific Officer Jack Higgins , and director & President and CEO Clay B Siegall .

Immunome Inc (IMNM) Insider Trades Summary

Over the past 18 months, Michael Lefenfeld made no insider transaction in Immunome Inc (IMNM). Other recent insider transactions involving Immunome Inc (IMNM) include a net purchase of 269,204 shares made by Clay B Siegall , a net purchase of 9,000 shares made by Jean Jacques Bienaime , and a net purchase of 42,300 shares made by Bruce Turner .

In summary, during the past 3 months, insiders sold 17,904 shares of Immunome Inc (IMNM) in total and bought 7,000 shares, with a net sale of 10,904 shares. During the past 18 months, 17,904 shares of Immunome Inc (IMNM) were sold and 320,504 shares were bought by its insiders, resulting in a net purchase of 302,600 shares.

Immunome Inc (IMNM)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Immunome Inc Insider Transactions

No Available Data

Michael Lefenfeld Mailing Address

Above is the net worth, insider trading, and ownership report for Michael Lefenfeld. You might contact Michael Lefenfeld via mailing address: Immunome, Inc., 665 Stockton Drive, Suite 300, Exton Pa 19341.